Advances in locoregional therapy for hepatocellular carcinoma combined with immunotherapy and targeted therapyOA
Locoregional therapies(LRTs)of hepatocellular carcinoma(HCC)represented by ablation and TACE has become the main means for the clinical treatment of unresectable HCC.Among these,TACE is used throughout the stageⅠb toⅢb of …查看全部>>
Jian Xue;Hongbo Ni;Fan Wang;Ke Xu;Meng Niu
Department of Interventional Radiology,The First Affiliated Hospital of China Medical University,Shenyang,Liaoning,110000,ChinaDepartment of Interventional Radiology,The First Affiliated Hospital of China Medical University,Shenyang,Liaoning,110000,ChinaDepartment of Interventional Radiology,The First Affiliated Hospital of China Medical University,Shenyang,Liaoning,110000,ChinaDepartment of Interventional Radiology,The First Affiliated Hospital of China Medical University,Shenyang,Liaoning,110000,ChinaDepartment of Interventional Radiology,The First Affiliated Hospital of China Medical University,Shenyang,Liaoning,110000,China
医药卫生
Hepatocellular carcinomaLocoregional therapyImmunotherapyTargeted therapyCombination therapy
《介入医学杂志(英文)》 2021 (3)
P.105-113,9
评论